INS and type 1 diabetes mellitus: A review by Peters et al12 demonstrated that 7 of the 13 episodes of eDKA due to canagliflozin were in patients with underlying T1DM and that infection, reduced food intake, increased physical activity, and large recent reductions in insulin doses served as precipitants of eDKA.